Recently, Amazon.com (NASDAQ:AMZN) has become one of my least-favorite investments to discuss. For starters, everyone wants to talk about Amazon stock, which is great for the first thousand go-arounds. But now, I feel like a one-hit wonder asked to play that song one more time.
Plus, I’m not sure what else I can add to the discussion. Whether you want to admit it or not, Amazon.com is the greatest company on earth. No one, not Alibaba (NYSE:BABA), not Microsoft (NASDAQ:MSFT), not even trillion-dollar Apple (NASDAQ:AAPL) can dethrone Jeff Bezos’ house.
So I’m often left to reiterate the obvious: Amazon.com will take over the world. By logical deduction, you’ll want exposure to Amazon stock, if you can afford it.
But in searching for any new angles for this all-angles-covered company, I realized something: we are grossly underestimating AMZN stock.
You read that correctly. The e-commerce giant, which has disrupted almost every single brick-and-mortar retailer, and is stridently pushing into new sectors, is undervalued.
Best Undervalued Stocks To Own Right Now: Exelon Corporation(EXC)
Advisors' Opinion:- [By Logan Wallace]
US Bancorp DE trimmed its position in shares of Exelon (NYSE:EXC) by 9.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 157,712 shares of the energy giant’s stock after selling 15,626 shares during the quarter. US Bancorp DE’s holdings in Exelon were worth $6,153,000 at the end of the most recent reporting period.
- [By Logan Wallace]
Banco de Sabadell S.A bought a new position in Exelon Co. (NYSE:EXC) in the 1st quarter, HoldingsChannel.com reports. The firm bought 15,909 shares of the energy giant’s stock, valued at approximately $610,000.
- [By Stephan Byrd]
Investors bought shares of Exelon (NYSE:EXC) on weakness during trading on Wednesday. $34.07 million flowed into the stock on the tick-up and $18.56 million flowed out of the stock on the tick-down, for a money net flow of $15.51 million into the stock. Of all stocks tracked, Exelon had the 24th highest net in-flow for the day. Exelon traded down ($0.42) for the day and closed at $39.79
- [By Shane Hupp]
Investors sold shares of Exelon Co. (NYSE:EXC) on strength during trading hours on Thursday. $15.04 million flowed into the stock on the tick-up and $55.72 million flowed out of the stock on the tick-down, for a money net flow of $40.68 million out of the stock. Of all stocks tracked, Exelon had the 21st highest net out-flow for the day. Exelon traded up $0.32 for the day and closed at $44.44
- [By Joseph Griffin]
Skba Capital Management LLC reduced its stake in Exelon Co. (NYSE:EXC) by 1.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 199,350 shares of the energy giant’s stock after selling 2,000 shares during the quarter. Skba Capital Management LLC’s holdings in Exelon were worth $8,492,000 at the end of the most recent quarter.
Best Undervalued Stocks To Own Right Now: Hollysys Automation Technologies Ltd.(HOLI)
Advisors' Opinion:- [By Lisa Levin]
Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares were also up, gaining 24 percent to $27.3947 following Q3 results.
Equities Trading DOWN
- [By Stephan Byrd]
Hollysys Automation Technologies (NASDAQ: HOLI) and GrafTech (NYSE:EAF) are both industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.
- [By Lisa Levin] Gainers Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results. MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58. Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82. Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82. Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings. Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69. PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42. LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results. Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results. Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37. Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
- [By Dan Caplinger]
The stock market finally hit some resistance on Tuesday, giving up ground and breaking a long streak of consecutive advances for most major benchmarks. Market participants got spooked by a rise in interest rates, with 10-year Treasury yields once again climbing above the 3% mark and leading some to predict even steeper advances in the future. With budget deficits ballooning, higher interest expenses on the national debt could have a dramatic impact on the U.S. economy, especially if it lures investors away from high-flying stocks. Yet even amid the bond-driven downturn, some individual companies saw good news lift their shares. Valeant Pharmaceuticals International (NYSE:VRX), Hollysys Automation Technologies (NASDAQ:HOLI), and Ascena Retail Group (NASDAQ:ASNA) were among the best performers on the day. Here's why they did so well.
- [By Shane Hupp]
Bloom Energy (NASDAQ: HOLI) and Hollysys Automation Technologies (NASDAQ:HOLI) are both oils/energy companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.
- [By Rich Smith]
China's Hollysys Automation Technologies (NASDAQ:HOLI) stock is up 14.3% as of 11:30 a.m. EDT, after hitting a high as much as 26% above yesterday's close earlier this morning.
Best Undervalued Stocks To Own Right Now: James River Group Holdings, Ltd.(JRVR)
Advisors' Opinion:- [By Joseph Griffin]
James River Group (NASDAQ:JRVR) and Conifer (NASDAQ:CNFR) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.
- [By Motley Fool Transcribers]
James River Group Holdings Ltd (NASDAQ:JRVR)Q4 2018 Earnings Conference CallFeb. 22, 2019, 8:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Shane Hupp]
Comerica Bank lifted its stake in shares of James River Group Holdings Ltd (NASDAQ:JRVR) by 318.1% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 119,204 shares of the insurance provider’s stock after buying an additional 90,695 shares during the quarter. Comerica Bank owned 0.40% of James River Group worth $4,708,000 as of its most recent filing with the SEC.
No comments:
Post a Comment